Over the past few years, many investors have avoided developed international equity markets for a variety of reasons: anemic growth, disappointing economic data and geopolitical uncertainty. Brian Manby discusses reasons why investors should be optimistic about international equities again.
International equity markets have made headlines this year for all the wrong reasons with lackluster performance and looming uncertainty. Should investors acquiesce and hold on for the ride? Our international multifactor approach offers investors a unique approach toward developed international equity markets.
After 24 months of live performance, the WisdomTree U.S. Multifactor Fund (USMF) has met the objectives that were set out when it was launched and has the potential to generate higher absolute returns over the long run. Alejandro Saltiel examines how this factor strategy performed over the last two years.
While we remain optimistic that a U.S.–China trade deal will ultimately be reached, investors need greater transparency into what’s performing (or not) in the Chinese equity market. To help, we’ve created tools that break down performance by a variety of factors including share class.
Over the last 10 years, value as a factor has lagged the market, but recent market activity is starting to point to a potential comeback in this investment style. We believe our dividend-weighted family represents a deeper cut of value because it leaves out zero-dividend-paying (growthier) stocks.